RESTON, Virginia, Oct. 22 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging posted the following news release:

* * *

Real-World Results Confirm Benefit of PSMA Therapy for Prostate Cancer

*

Graphical Abstract: Overview of real-world treatment patterns and clinical outcomes with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer treated within the French Early-Access Program. The figure . . .

Click here for more information about our products